Acetyl Tetrapeptide-9
A cosmetic peptide marketed for firmness and dermal support. Peptide-specific clinical evidence is sparse and is mainly embedded in multi-ingredient formulations.
- Human evidencen/a
- Animal evidencen/a
- Mechanisticn/a
- Safety knowledgen/a
- Editorial confidence2/5
Evidence Snapshot
- Overall
- 0/5None identified
- Human
- 0/5None identified
- Animal
- 0/5None identified
- In-vitro
- 0/5None identified
- Safety
- 0/5None identified
Scientific identity
- Peptide family
- Dermal matrix cosmetic peptide
- Entity class
- Cosmetic peptide
- Alternative names
- DermicanAcetyl tetrapeptide 9
Developed as a topical cosmetic peptide under the trade name Dermican, with proposed effects on dermal matrix organisation.
Proposed Mechanisms
- not-yet-documentedpending-editorial-review
- Collagen synthesis →limited
Reported / Studied Uses
- Skin Ageing / WrinklesEvidence · insufficient
Human Evidence
No robust independent randomized trial isolating acetyl tetrapeptide-9 was identified.
Animal Evidence
No robust animal evidence specific to routine cosmetic use was identified.
Safety & Unknowns
Regulatory Status
| Country | Status | Notes |
|---|
Community Observations
References
- No verified references linked yet. Editors will add primary sources.
Full Disclaimer
This page is for educational information only. It does not constitute medical advice, diagnosis, treatment, dosing guidance, or a recommendation to use any peptide, medicine or research chemical. Many peptides discussed on Atlas are not approved for human use in most jurisdictions and may have limited or unknown long-term safety data.
Community observations shown on this page are anonymised, moderated and observational only. They do not establish safety or effectiveness.
Always consult a qualified healthcare professional before making decisions about your health. See medical disclaimer and methodology.